BMS-986001 Bone, Metabolic Data Compare Well to Tenofovir Through 48 Weeks
Myles Helfand, TheBodyPRO.com; Posted Oct 10, 2:09 p.m. ET
Although most eyes have been focused on the development of tenofovir alafenamide fumarate (TAF), a less-toxic prodrug of tenofovir (Viread), another thymidine analog is moving through development as well. We spoke with Grace McComsey, M.D., about the latest data.
Why We Must Not Ignore the Lives of Older Black Gay Men
Craig Washington, HIV Prevention Justice Alliance; Posted Oct 9, 12:15 p.m. ET
How do we include black gay men over 50 when we talk about the way HIV affects black gay men?
Moving Forward the National Agenda for Women Living With HIV
Rusti Miller-Hill, TheBody.com; Posted Oct 8, 5:17 p.m. ET
Rusti Miller-Hill recently attended the PWN Summit in Florida. Here are her thoughts on the future of funding for programs and services for women living with HIV.
HIV Criminalization: Another Way to Lock Up Young Black Men
Robert Suttle, HIV Prevention Justice Alliance; Posted Oct 8, 3:32 p.m. ET
How does criminalization disproportionately affect young black gay men in the South?
Everyone living with HIV has a story to tell. Find out how to share your own experiences in one or both of the series below, which feature the writings of readers like you.
Regardless of where or how it happened, the day you received your HIV-positive diagnosis was likely among the most intense days you'll ever live through. Some of TheBody.com's readers have generously shared their experiences -- to reflect on how they've changed, and so that others would know that they too can survive, and even thrive, following that fateful day. How did you get through it?
Many types of medications can save or improve lives, but they can also have unintended consequences. For some people living with HIV, taking meds can be a complicated cycle -- and for others, a Sunday stroll. Medication side effects can be mild or life altering, horrible or even pleasurable; some people living with HIV never experience any at all. It seems like everyone's got a story about side effects. What's yours?
Openly Gay, HIV-Positive Candidate in Michigan Endorsed by Black Clergy
Sue Saltmarsh, TheBody.com; Posted Oct 8, 3:17 p.m. ET
"We can all take steps to lead in our communities, whether we're living with HIV or diabetes or we're completely healthy," says Todd Heywood. "We have an obligation to build up our community and make it better than it was when we got there."
What New HIV Research Will IDWeek 2014 Have in Store?
Myles Helfand, TheBodyPRO.com; Posted Oct 8, 2:52 p.m. ET
The last major U.S. medical conference of the year that highlights HIV is about to begin! Here's a look at some of the sessions we'll be attending during IDWeek 2014, and what we hope to learn from them.
Notes on the "We Are Here" Blog Tour
Charles Stephens , HIV Prevention Justice Alliance; Posted Oct 7, 5:47 p.m. ET
What does it mean to be black and gay in the U.S. South? Charles Stephens discusses that.
Working While Positive: People With HIV Share Job Search Strategies
Sue Saltmarsh, TheBody.com; Posted Oct 6, 9:31 p.m. ET
Is fear holding you back? Go job-hunting with these "arrows" to hit a bull's-eye with prospective employers.
My Health Tracker can help you organize your HIV treatment information privately and securely in one place. This way, you can take better charge over your health, and you and your doctor can have even more productive conversations about your treatment.
Registration takes only a couple of minutes, requires no personal info, and you'll be able to pick up where you left off at any time.
Medicines Patent Pool Signs With 6 Manufacturers to Develop Generic Tenofovir Alafenamide
Katherine Moriarty, TheBodyPRO.com; Posted Oct 6, 5:28 p.m. ET
The companies will begin development plans for generic production of a promising, new HIV product simultaneously with the FDA's review to expedite access to low- and middle-income countries once the medicine is approved.
Newly Identified Marker Helps Predict Tuberculosis Complications in HIV Patients
National Institute of Allergy and Infectious Diseases; Posted Oct 6, 12:55 p.m. ET
The study is the first to link a an innate immune cell, CD14++CD16- monocyte, to the development of IRIS. If these results hold firm in additional patients, monocytes may be used to identify patients at-risk for the disease.
Transgender Services and Clinics: Interviews at AIDS 2014 With JoAnne Keatley and Beatriz Grinsztejn
Simon Collins, HIV i-Base; Posted Oct 6, 12:43 p.m. ET
JoAnne Keatley is a leading transgender activist and Dr. Beatriz Grinsztejn developed the first transgender HIV clinic in Rio de Janiero.
HIV and Transgender Issues at AIDS 2014
Simon Collins, HIV i-Base; Posted Oct 6, 12:42 p.m. ET
Where available -- and information is scarce even from resource-rich countries -- data increasingly report very high rates of HIV in transgender people, especially those who have sex with men.
>> Browse Older Featured Stories